289 related articles for article (PubMed ID: 17307328)
1. Identification of imatinib mesylate degradation products obtained under stress conditions.
Szczepek WJ; Kosmacińska B; Bielejewska A; Łuniewski W; Skarzyński M; Rozmarynowska D
J Pharm Biomed Anal; 2007 Apr; 43(5):1682-91. PubMed ID: 17307328
[TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate.
Al-Hadiya BM; Bakheit AH; Abd-Elgalil AA
Profiles Drug Subst Excip Relat Methodol; 2014; 39():265-97. PubMed ID: 24794909
[TBL] [Abstract][Full Text] [Related]
3. Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form.
Vadera N; Subramanian G; Musmade P
J Pharm Biomed Anal; 2007 Jan; 43(2):722-6. PubMed ID: 16920319
[TBL] [Abstract][Full Text] [Related]
4. Nonaqueous capillary electrophoresis of imatinib mesylate and related substances.
Ye L; Huang Y; Li J; Xiang G; Xu L
J Sep Sci; 2012 Aug; 35(16):2108-13. PubMed ID: 22753368
[TBL] [Abstract][Full Text] [Related]
5. Determination of imatinib mesylate and related compounds by field amplified sample stacking with large volume sample injection capillary electrophoresis.
Li J; Huang Y; Huang L; Ye L; Zhou Z; Xiang G; Xu L
J Pharm Biomed Anal; 2012 Nov; 70():26-31. PubMed ID: 22677653
[TBL] [Abstract][Full Text] [Related]
6. Isolation and structure elucidation of degradation products in the potential anticancer drug PAC-1.
Song Z; Chen X; Zhang D; Gong P; Bi K
J Pharm Biomed Anal; 2010 Mar; 51(4):965-8. PubMed ID: 19889506
[TBL] [Abstract][Full Text] [Related]
7. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
[TBL] [Abstract][Full Text] [Related]
8. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
Tiwari RN; Bonde CG
J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
[TBL] [Abstract][Full Text] [Related]
9. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Nageswari A; Reddy KV; Mukkanti K
J Pharm Biomed Anal; 2012 Jul; 66():109-15. PubMed ID: 22502910
[TBL] [Abstract][Full Text] [Related]
10. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride.
Bansal G; Singh M; Jindal KC; Singh S
J Pharm Biomed Anal; 2008 Nov; 48(3):788-95. PubMed ID: 18804934
[TBL] [Abstract][Full Text] [Related]
11. Study of forced decomposition behavior of lamivudine using LC, LC-MS/TOF and MS(n).
Bedse G; Kumar V; Singh S
J Pharm Biomed Anal; 2009 Jan; 49(1):55-63. PubMed ID: 19022602
[TBL] [Abstract][Full Text] [Related]
12. Study of polymorphism in imatinib mesylate: a quantum chemical approach using electronic and vibrational spectra.
Srivastava A; Joshi BD; Tandon P; Ayala AP; Bansal AK; Grillo D
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Feb; 103():325-32. PubMed ID: 23261630
[TBL] [Abstract][Full Text] [Related]
13. Characterization of degradation products of amorphous and polymorphic forms of clopidogrel bisulphate under solid state stress conditions.
Raijada DK; Prasad B; Paudel A; Shah RP; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):332-44. PubMed ID: 19520540
[TBL] [Abstract][Full Text] [Related]
14. Hydrolytic degradation of azimsulfuron, a sulfonylurea herbicide.
Boschin G; D'Agostina A; Antonioni C; Locati D; Arnoldi A
Chemosphere; 2007 Jul; 68(7):1312-7. PubMed ID: 17328940
[TBL] [Abstract][Full Text] [Related]
15. HPLC study of glimepiride under hydrolytic stress conditions.
Kovaríková P; Klimes J; Dohnal J; Tisovská L
J Pharm Biomed Anal; 2004 Sep; 36(1):205-9. PubMed ID: 15351067
[TBL] [Abstract][Full Text] [Related]
16. Stability-indicating study of the anti-Alzheimer's drug galantamine hydrobromide.
Marques LA; Maada I; de Kanter FJ; Lingeman H; Irth H; Niessen WM; Giera M
J Pharm Biomed Anal; 2011 Apr; 55(1):85-92. PubMed ID: 21300511
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey.
Johnson BM; Kamath AV; Leet JE; Liu X; Bhide RS; Tejwani RW; Zhang Y; Qian L; Wei DD; Lombardo LJ; Shu YZ
Drug Metab Dispos; 2008 Dec; 36(12):2475-83. PubMed ID: 18787055
[TBL] [Abstract][Full Text] [Related]
18. Stability and characterization of perphenazine aerosols generated using the capillary aerosol generator.
Li X; Blondino FE; Hindle M; Soine WH; Byron PR
Int J Pharm; 2005 Oct; 303(1-2):113-24. PubMed ID: 16139453
[TBL] [Abstract][Full Text] [Related]
19. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil.
Mehta S; Shah RP; Priyadarshi R; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):345-54. PubMed ID: 19505786
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and mechanism of the hydrolysis of thiamethoxam.
Karmakar R; Singh SB; Kulshrestha G
J Environ Sci Health B; 2009 Jun; 44(5):435-41. PubMed ID: 20183047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
